Sign in

NCT07736014Completed

Adapted Physical Activity and Tango-Based Therapy for Parkinson's Disease: A Pilot Study

Effectiveness of Tango Therapy and Physical Reconditioning in Individuals With Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 30 Jul 2026

Brief summary (registry, in English)

The purpose of this clinical research is to evaluate the effectiveness of a structured Tango-based (Riabilitango®) therapy compared to a conventional Motor Reconditioning program and a Control group in individuals diagnosed with Parkinson's Disease. The study assesses changes in motor performance, balance, gait kinematics, functional strenght, and health-related quality of life over a 3-month intervention period and a 3-month post-intervention follow-up.

Status (registry)
Completed
Study type
Interventional
Enrollment
27 (actual)
First submitted
24 Jul 2026
Start date
17 Oct 2024
Primary completion date
31 Jul 2025
Lead sponsor
University of Foggia
NCT number
NCT07736014

What you commit to

  • Study type: Interventional
  • Participants enrolled: 27
  • From 17 Oct 2024 to the primary completion date, 31 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Surgical interventions that directly affect mobility or dynamic balance (e.g., Deep Brain Stimulation or recent major orthopedic surgery).
  • Concurrent participation in other physical rehabilitation programs or clinical trials during the study period.

Other illness

  • Severe cognitive impairment or dementia preventing comprehension of instructions or active participation.
  • Severe cardiovascular, respiratory, orthopedic, or other neurological conditions that impair safe exercise participation or gait evaluation.

Who the study is looking for

  • Confirmed clinical diagnosis of idiopathic Parkinson's Disease.
  • Mild to moderate disease severity (Hoehn and Yahr stage I-III).
  • Ability to walk independently (with or without assistive devices).
  • Stable antiparkinsonian pharmacological treatment for at least 4 weeks prior to enrollment.
  • Ability to understand study procedures and willingness to sign the Informed Consent document.

Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia
Coordinator of this site? Confirm its status
FoggiaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.